Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M105975200 on September 18, 2001

J. Biol. Chem., Vol. 276, Issue 48, 45330-45340, November 30, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/48/45330    most recent
M105975200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korn, T.
Right arrow Articles by Koepsell, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korn, T.
Right arrow Articles by Koepsell, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Plasma Membrane-associated Protein RS1 Decreases Transcription of the Transporter SGLT1 in Confluent LLC-PK1 Cells*

Thomas KornDagger, Thomas KühlkampDagger, Christina Track, Irina Schatz, Katharina Baumgarten, Valentin Gorboulev, and Hermann Koepsell§

From the Institute of Anatomy of the Bayerische Julius-Maximilians-Universität, 97070 Würzburg, Germany

Received for publication, June 27, 2001, and in revised form, September 5, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Previously we cloned RS1, a 67-kDa polypeptide that is associated with the intracellular side of the plasma membrane. Upon co-expression in Xenopus laevis oocytes, human RS1 decreased the concentration of the Na+-D-glucose co-transporter hSGLT1 in the plasma membrane (Valentin, M., Kühlkamp, T., Wagner, K., Krohne, G., Arndt, P., Baumgarten, K., Weber, W.-M., Segal, A., Veyhl, M., and Koepsell, H. (2000) Biochim. Biophys. Acta 1468, 367-380). Here, the porcine renal epithelial cell line LLC-PK1 was used to investigate whether porcine RS1 (pRS1) plays a role in transcriptional up-regulation of SGLT1 after confluence and in down-regulation of SGLT1 by high extracellular D-glucose concentrations. Western blots indicated a dramatic decrease of endogenous pRS1 protein at the plasma membrane after confluence but no significant effect of D-glucose. In confluent LLC-PK1 cells overexpressing pRS1, SGLT1 mRNA, protein, and methyl-alpha -D-glucopyranoside uptakes were drastically decreased; however, the reduction of methyl-alpha -D-glucopyranoside uptake after cultivation with 25 mM D-glucose remained. In confluent pRS1 antisense cells, the expression of SGLT1 mRNA and protein was strongly increased, whereas the reduction of SGLT1 expression during cultivation with high D-glucose was not influenced. Nuclear run-on assays showed that the transcription of SGLT1 was 10-fold increased in the pRS1 antisense cells. The data suggest that RS1 participates in transcriptional up-regulation of SGLT1 after confluence but not in down-regulation by D-glucose.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Because D-glucose has a key role in cellular metabolism, organisms dispose of highly efficient mechanisms to control transepithelial absorption of D-glucose in the small intestine and kidney and the D-glucose uptake into glucose-metabolizing cells. In the kidney and small intestine, D-glucose is translocated across epithelial cells by the consecutive operation of glucose transporters that belong to the following two gene families: secondary active Na+-D-glucose co-transporters of the SGLT family in the brush-border membrane, and Na+-independent glucose transporters of the GLUT family in the basolateral membrane (1, 2). The regulation of glucose transport affects transporters of both families, is cell type-specific, and is brought about by various mechanisms (1, 3). The regulation of glucose transport has pivotal physiological and biomedical importance. For example (i) one of the biological effects of insulin is the stimulation of D-glucose uptake into fat cells by GLUT4 (4, 5). (ii) The D-glucose absorption in small intestine is adapted to diet by glucose-dependent regulation of the high affinity Na+-D-glucose co-transporter SGLT1 (6, 7). (iii) The capacity of the D-glucose reabsorption in the proximal tubule is one of the factors that determined D-glucose plasma levels in diabetic patients (8). (iv) The glomerulosclerosis observed in diabetes may be explained by the up-regulation of GLUT1 in mesangium cells, which triggers the overproduction of matrix proteins (9, 10).

Regulation of SGLT1 has been studied in small intestine (7, 11-13), in Xenopus oocytes (14), and in the renal epithelial cell line LLC-PK1 which is derived from porcine kidney proximal tubule cells (15-22). One of the factors that affect the expression of SGLT1 in small intestine and LLC-PK1 cells is extracellular D-glucose concentration (7, 17, 18). However, with increasing D-glucose the expression of SGLT1 in small intestine was increased, whereas it was decreased in LLC-PK1 cells, and the regulatory specificity for SGLT1 remained ambiguous. Another factor observed in cell culture is cell confluence. During confluence of LLC-PK1 cells, up-regulation of SGLT1 was observed, together with other differentiation-specific gene products of kidney proximal tubules such as tight junctions and brush-border enzymes (16, 19, 22-24). The confluence-dependent regulation of SGLT1 in LLC-PK1 cells appears to be mediated by protein kinases. Before confluence, activity of protein kinase C is high, and the mRNA level of SGLT1 is very low. After confluence, protein kinase C is down-regulated, whereas protein kinase A is up-regulated, and the level of SGLT1 mRNA is largely increased (19, 22, 24). One of the effects of protein kinase A is to enhance message stability, mediated by a specific RNA-binding protein (20, 21, 25).

Some years ago, we cloned RS1, a hydrophilic 67-kDa polypeptide from porcine kidney cortex that changed the expression of SGLT1 in Xenopus oocytes (26). Preliminary immunohistochemical experiments suggested that RS1 is localized at the extracellular side of the brush-border membrane and interacts specifically with SGLT1 (26, 27). Based on these findings, we put forward the hypothesis that RS1 is a subunit of SGLT1. This hypothesis was recently abandoned because we found that RS1 is actually localized at the intracellular face of the plasma membrane and that overexpression of human RS1 in Xenopus oocytes not only decreased the expression of human SGLT1 but also that of the human organic cation transporter hOCT2 (28, 29). In the present study, LLC-PK1 cells were used to investigate the putative role of RS1 in the regulation of SGLT1 expression and activity by cell confluence and extracellular glucose concentration. Evidence is provided that RS1 is involved in the confluence-dependent regulation of SGLT1 by decreasing the expression of SGLT1 in nonconfluent LLC-PK1 cells via down-regulation of mRNA transcription. A role of RS1 in the glucose-dependent regulation of SGLT1 could not be detected.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Culture-- The porcine renal epithelial cell line LLC-PK1 (15) was maintained in Dulbecco's modified Eagle's medium (DMEM)1 that contained 5 mM D-glucose and was supplemented with 10% (v/v) fetal bovine serum, 5 mM L-glutamine, 0.1 mg/ml streptomycin sulfate, and 100 units/ml penicillin G. In some experiments, D-glucose concentration was adjusted to 25 mM. Cells were grown at 37 °C on Petri dishes in the presence 5% (v/v) CO2, and the culture medium was replaced every 2-3 days. When seeded at a density of 104 cells/cm2, confluence was reached in about 6 days. For passaging or transport measurements, the cells were detached by incubation for 30 min at 37 °C in Ca2+- and Mg2+-free Dulbecco's phosphate-buffered saline (DPBS) that was supplemented with 28 mM NaHCO3, 0.5 mM EDTA, 10 mM Hepes, pH 7.4 (30). Subsequently cells were harvested, pelleted by 3-min centrifugations at 250 × g, and resuspended in culture medium or transport assay buffer.

Constructs for the Expression of Sense and Antisense RS1-- For overexpression, porcine RS1 (pRS1) in pBluescriptII SK plasmid (26) was restricted with BglII and HindIII, filled in with Klenow polymerase, ligated to BstXI adaptors, and inserted at the BstXI site of the eucaryotic expression vector pRcCMV from Invitrogen (Leek, Netherlands). The correct orientation of pRS1 was verified by restriction analysis and DNA sequencing (pRcCMV-pRS1). For the overexpression of antisense RS1 RNA, a 1481-bp fragment of pRS1 cDNA (nucleotides (nt) 1-1481, GenBankTM accession number X64315), which encompassed the ATG translation initiation codon, was ligated to BstX1 adaptors and inserted into the pRcCMV vector. A correct RS1 antisense clone (pRcCMV anti-pRS1) was identified by restriction analysis and DNA sequencing. Analogously, an 1845-bp cDNA fragment of pRS1 (nt 1-1845) was cloned in reverse orientation into the pIND vector from Invitrogen (pIND anti-pRS1). The pIND plasmid is under control of the minimal heat shock promoter (PDelta HSP) and of a modified ecdysone response element. It also confers the neomycin resistance gene. pIND anti-pRS1 was co-transfected with the pVgRXR plasmid (Invitrogen) that encodes receptors for ecdysone and retinoid X and contains a ZeocinTM resistance gene. After co-transfection of pIND-anti-RS1 with pVgRXR, the PDelta HSP promoter is induced when the cells are treated with muristerone A (31). Muristerone A binds to ecdysone/retinoid X receptor heterodimers that subsequently interact with a response element on the pIND vector, thereby activating the transcription of antisense pRS1 RNA from the minimal heat shock promoter (32). As another control for RS1 antisense experiments, the porcine oxytocin receptor (nt 1-1184, GenBankTM accession number X71796) was cloned in reverse orientation into the pRcCMV vector (pRcCMV anti-oxytocin).

Stable Transfection of LLC-PK1 Cells-- Native LLC-PK1 cells grown in DMEM were transfected with pRcCMV-pRS1, pRcCMV anti-pRS1, the empty pRcCMV plasmid, pRcCMV anti-oxytocin, or pIND anti-RS1 plus pVgEcR using Lipofectin reagent from Life Technologies, Inc. After transfection, the cells were kept in DMEM for 2 days. Selection was initiated by adding geneticin (G418) to the culture medium (0.4 mg/ml for 1 week and 0.8 mg/ml later). Single clones were isolated after 3 weeks and amplified in DMEM containing 0.8 mg/ml G418. Genomic integration of the pRcCMV antisense pRS1 constructs and their transcription were tested by polymerase chain reactions (PCRs) without and with reverse transcription, respectively. The employed primers were derived from the T7 region of the CMV promoter (sense, 5'-TAA TAC GAC TCA CTA TAG GG-3') and from the cDNA sequence of pRS1 (antisense, 5'-CTT AAT TCA GCA GGC GG-3', nt 793-809 (26)). For reverse transcriptase-PCR, a primer downstream from the T7 promoter (sense, 5'-GCT TGG TAC CGA GCT CGG-3') was used together with the above described pRS1-specific antisense primer. In LLC-PK1 cells transfected with pIND anti-RS1 plus pVgEcR, transcription of pRS1 antisense mRNA was induced by cultivating the cells for 2 days in the presence of 5 µM muristerone A.

Northern Analysis-- For Northern blots mRNA was isolated from LLC-PK1 cells (33). In some experiments the transcription was blocked by addition of 5,6-dichloro-1-beta -D-ribofuranosylbenzimidazole (DRB) to culture medium. 5 µg of mRNA per lane were resolved on glyoxal-agarose gels, blotted to Hybond-N membrane (Amersham Pharmacia Biotech), cross-linked by UV irradiation, and hybridized to double-stranded cDNA probes of various genes that were labeled with [alpha -32P]dATP (34). The blots were stripped and reprobed several times. The probes were derived from pRS1 (26) (nt 577-1680), porcine Na+-D-glucose co-transporter pSGLT1 (17) (nt 1546-1818), human sodium-independent glucose transporter hGLUT1 (35) (nt 1-2856), human polyspecific cation transporter hOCT2 (36) (nt 1-1703), porcine vasopressin receptor pV2R (37) (nt 1-1494), human glyceraldehydephosphate dehydrogenase hGAPDH (1.1-kb fragment from CLONTECH, Heidelberg, Germany), and human ubiquitin (260-bp fragment from CLONTECH). For porcine cDNA probes, the membranes were washed at a final stringency of 0.25× SSPE (0.18 mM NaCl, 10 mM sodium phosphate, pH 7.7, 1 mM EDTA), 0.1% (w/v) SDS at 42 °C. For the human probes, 1× SSPE was used in the final stringency buffer. In some experiments, the autoradiographic signals detected on x-ray films were quantified by digitizing the stained bands and subtracting the background staining (Sigmascan program from Sigma, Deisenhofen, Germany).

Nuclear Run-on Transcription Assay-- The employed experimental protocol was adapted from procedures described previously (38, 39). LLC-PK1 cells were grown with 5 mM D-glucose in the medium until 5 days after confluence, washed with phosphate-buffered saline (0.01 M Na2HPO4, 0.15 M NaCl, pH 7.4), harvested, and lysed with lysis buffer that consisted of 0.01 M Tris-HCl, pH 7.4, 3 mM MgCl2, 0.5% (w/v) Nonidet P-40, and 1 mM phenylmethylsulfonyl fluoride (PMSF). The nuclei were spun down by a 5-min centrifugation at 4000 × g (4 °C), washed three times with lysis buffer, and stored at -70 °C in 0.02 M Tris-HCl, pH 7.9, 0.075 M NaCl, 0.5 mM EDTA, 0.85 mM dithiothreitol, 0.125 mM PMSF, 50% (v/v) glycerol, and 32 units/ml ribonuclease inhibitor. Transcription was initiated by adding 107 nuclei to 100 µl of assay buffer that contained 0.1 M Tris-HCl, pH 7.9, 0.05 M NaCl, 0.4 mM EDTA, 0.34 M (NH4)2SO4, 4 mM MnCl2, 0.05 mM PMSF, 0.6 mM dithiothreitol, 2 mM ATP, 2 mM GTP, 2 mM CTP, 250 µCi of [alpha -32P]UTP, 0.25 mg/ml heparin sulfate, and 0.5 units/ml ribonuclease inhibitor. After 30 min of incubation at 30 °C, the reaction was stopped by adding RNase-free DNase and CaCl2 to final concentrations of 750 units/ml and 1 mM, respectively. Then proteinase K (0.5 mg/ml), yeast transfer RNA (0.33 mg/ml), SDS (1.5%), EDTA (10 mM), and Tris-HCl (15 mM, pH 7.4) were added, and the mixture was incubated for 30 min at 45 °C. The labeled RNA transcripts were isolated using 4 M guanidinium isothiocyanate and phenol/chloroform extraction, followed by two isopropyl alcohol precipitations. They were suspended in 200 µl of 20 mM Tris-HCl, pH 7.9, and 20 mM EDTA, and the labeled RNA transcripts were quantified by beta -counting. As hybridization templates, purified cDNA fragments were immobilized on nylon filters (pSGLT1, nt 1546-1818; hGAPDH, nt 197-806; hGLUT1, nt 1-2856; hOCT2, nt 1-1703; lac repressor lacI of Escherichia coli, nt 123-1629). Per dot, 2 µg of cDNA fragment heated to 95 °C were applied to filters and fixed by UV cross-linking plus 2 h of incubation at 80 °C. The filters were prehybridized by 2 h of incubation at 42 °C with 5× SSPE, 5× Denhardt's solution, 0.5% SDS, 50% formamide, 500 µg/ml yeast tRNA, and 100 µg/ml polyadenylic acid (hybridization buffer). For hybridization, the filters were incubated for 20 h at 42 °C with hybridization buffer containing equal amounts of the radioactively labeled mRNAs (25 × 107 cpm per filter) that had been denatured (5 min, 65 °C). Washing was performed one time for 15 min at 42 °C with 2× SSPE, 0.1% SDS, one time for 30 min at 37 °C with 2× SSPE containing 10 µg/ml RNase A, and one time for 30 min at 42 °C with 1× SSPE containing 0.1% SDS. Filters were exposed for autoradiography to x-ray film for 7 days at -70 °C.

Western Blotting-- Plasma membranes from LLC-PK1 cells were enriched by differential centrifugation as described previously (40). Briefly, the cells were scraped with a rubber policeman into ice-cold Hepes buffer (10 mM Hepes/Tris, pH 7.4, containing 30 mM mannitol, 10 mM CaCl2, 0.5 mM PMSF, 1 mM benzamidine, 5 µg/ml aprotinin, 5 µg/ml leupeptin), homogenized in a Teflon potter, and incubated for 10 min on ice. Nuclei and cell debris were removed by 15 min of centrifugation at 5000 × g at 8 °C. The supernatant, termed homogenate, was centrifuged for 30 min at 40,000 × g at 8 °C. The resulting pellet enriched in plasma membranes was termed PME (see upper lane of Fig. 2a). Membrane-free cytosolic proteins were prepared by centrifuging the 40,000 × g supernatant for 2 h at 200 000 × g at 8 °C. For SDS-polyacrylamide gel electrophoresis, protein samples were incubated for 1 h at 37 °C in 50 mM Na2HPO4, pH 6.8, 4 M urea, 0.25 M beta -mercaptoethanol, 1% (w/v) SDS, and 0.0005% (w/v) bromphenol blue. If immunodetection of pRS1 was intended, the SDS-treated protein samples were subsequently acetylated (29). After SDS-polyacrylamide gel electrophoresis performed according to Laemmli (41), the proteins were electrophoretically transferred to nitrocellulose membranes by semi-dry blotting (42). The nitrocellulose membranes were blocked for 1 h at 25 °C in blocking buffer (50 mM Tris-HCl, pH 8.0, containing 137 mM NaCl, 2.7 mM KCl, 0.05% (w/v) Tween 20, and 2% (w/v) skimmed milk powder). For antibody reaction, the blots were incubated for 2 h at 25 °C with affinity-purified polyclonal rabbit antibodies against porcine SGLT1 (pSGLT1-ab) or porcine RS1 (pRS1-ab) that were diluted 1:10 or 1:2500 in blocking buffer, respectively. The antibodies have been described earlier (29, 43). pSGLT1-ab are raised against the amino acids 525-542 of porcine SGLT1 and affinity-purified on the antigenic peptide fixed to Sepharose, whereas pRS1-ab was raised against recombinant pRS1 protein expressed in E. coli and affinity-purified on the recombinant protein fixed to enzyme-linked immunosorbent assay plates. After washing the blots with the blocking buffer they were incubated for 1 h at 25 °C with peroxidase-conjugated goat anti-rabbit IgG antiserum that was diluted 1:5000 in blocking buffer. Blots were then washed with blocking buffer, and bound label was visualized by enhanced chemiluminescence (ECL System from Amersham Pharmacia Biotech).

Measurements of Na+-D-Glucose Co-transport Activity-- The procedure was adapted from Kimmich et al. (30). LLC-PK1 cells were detached from culture dishes by incubation for 20 min (37 °C, 5% CO2) in Ca2+- and Mg2+-free DPBS. After 3 min of centrifugation at 250 × g, the pelleted cells were suspended at a protein concentration between 5 and 10 mg/ml in DPBS (37 °C). Protein concentration was measured according to Bradford (44). For transport measurements, this stock suspension was kept at 37 °C. Measurements were started by adding 50 µl of the stock suspension into 200 µl of incubation medium that was shaken in a 37 °C water bath. The incubation medium consisted of DPBS containing nonradioactive methyl-alpha -D-glucopyranoside (AMG) plus 1.9 kBq of [14C]AMG. Nonspecific AMG uptake was measured in the presence of 100 µM phlorizin. Because control experiments showed that the uptake rate of 40 µM or 2 mM AMG was linear during an incubation period of more than 5 min, the cells were routinely incubated for 2.5 min at 37 °C. The transport measurement was stopped by removing 200 µl of transport assay mixture and adding it to 1 ml of ice-cold stop solution (DPBS containing 1 mM phlorizin). The uptake at time 0 was determined by adding the ice-cold stop solution together with the respective amount of AMG. After 1 min of centrifugation at 8000 × g, the supernatant was removed; 1 ml of stop solution was added, and the sample was centrifuged again. The supernatant was carefully removed, and 100 µl of 0.5% (w/v) Triton X-100 were added. The tubes were shaken for 1 h at room temperature; 1 ml of Quickszint (LumasafeTMPlus, Groningen, Netherlands) was added; the vial was closed, shaken vigorously, and counted in a beta -counter.

Statistics-- Means ± S.D. of phlorizin inhibitable uptake rates were calculated from uptake measurements that were performed after 0 and 2.5 min of incubation of LLC-PK1 cells. For each individual uptake measurement, four independent determinations were performed in the absence of phlorizin plus four determinations in the presence of phlorizin. The Michaelis-Menten equation was fitted to uptake rates determined for different substrate concentrations. For densitometric quantifications of Northern blots and nuclear run-on assays, three to four independent hybridizations were used per each experimental condition, employing samples from two or more independent cultivations. The unpaired Student's t test was used to evaluate the significance of differences between uptake rates or hybridization intensities.

Materials-- [alpha -32P]dATP (111 TBq/mmol) and [alpha -32P]dUTP (29.6 TBq/mmol) were obtained from ICN (Eschwege, Germany), [14C]AMG (11.25 GBq/mmol) from Amersham Pharmacia Biotech, and ribonuclease inhibitor and RNase-free DNase from Fermentas (St. Leon-Rot, Germany). Peroxidase-conjugated anti-rabbit IgG from goat, RNase A, DRB, Dulbecco's phosphate-buffered saline (DPBS), and polyadenylic acid were supplied by Sigma. Lipofectin and prestained marker proteins for SDS-polyacrylamide gel electrophoresis (BenchMarkTM) were supplied by Life Technologies, Inc., geneticin (G418) by Calbiochem, and Bradford protein assay by Bio-Rad. All other chemicals were obtained as described earlier (26, 43).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Endogenous Expression of SGLT1 and RS1 in LLC-PK1 Cells-- LLC-PK1 cells were derived from porcine kidney and exhibited properties similar to the S3 segment of the proximal tubule (15). They normally expressed both SGLT1 and RS1 (17, 26). Previously, it has been described (16-19) that the expression of SGLT1 in LLC-PK1 cells is up-regulated after confluence and repressed during cultivation in the presence of high D-glucose concentrations in the medium (25 versus 5 mM). As co-expression experiments of RS1 with SGLT1 in Xenopus oocytes suggested species-dependent up- or down-regulation of SGLT1 by RS1 (26, 29, 45), we investigated whether any alterations of pRS1 expression occur during the course of SGLT1 regulation by confluence and glucose concentrations. By confirming previous data, we observed that phlorizin-inhibitable uptake into subconfluent LLC-PK1 cells was very low and not significantly different after cultivation in low versus high D-glucose. In cells that were grown to about 60% confluence in the presence of 5 or 25 mM D-glucose, the phlorizin-inhibitable uptake of 40 µM AMG was 0.46 ± 0.07 and 0.35 ± 0.14 pmol × mg protein-1 × min-1, respectively (means ± S.D. of three independent experiments). After confluence, AMG uptake rates increased linearly for 5 days (data not shown). When these cells were grown in 5 or 25 mM D-glucose for 5 days upon reaching confluence, the initial phlorizin-inhibitable uptake rates of 40 µM AMG were 140.4 ± 29.8 (n = 3) and 27.3 ± 3.4 (n = 3) pmol × mg-1 × min-1, respectively (means ± S.D. of three independent experiments, p < 0.001 for difference, 81 ± 21% inhibition by cultivation with high glucose). The Northern blots in Fig. 1 show that the levels of SGLT1 mRNA were significantly increased after confluence in cells grown in 5 mM D-glucose. In contrast, in cells that were cultured in 25 mM D-glucose, the mRNA of SGLT1 was not increased after confluence. Similar effects were observed with the 3.9- and 2.2-kb transcripts of the pSGLT1 gene. The two transcripts differ in length of the 3'-untranslated region as a result of alternative polyadenylation (17). In contrast to SGLT1, the concentrations of RS1 mRNA before and after confluence were not significantly different in LLC-PK1 cells grown in 5 mM D-glucose. The mRNA level of RS1 also remained unchanged irrespective of whether the cells were grown in 5 mM of 25 mM D-glucose (Fig. 1).


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 1.   Northern blot analysis of SGLT1 and RS1 mRNA in subconfluent and confluent native LLC-PK1 cells grown in low or high D-glucose. Native LLC-PK1 cells were grown on culture plates with 5 mM D-glucose (5G) or 25 mM D-glucose (25G). Two days before confluence (subconfl.) and 5 days after confluence (confl.), cells were harvested, and mRNA was isolated. Northern blots were prepared and hybridized with a cDNA probe for pSGLT1 (SGLT1), stripped, hybridized with a cDNA probe for pRS1 (RS1), stripped again, and hybridized with cDNA probe for hGAPDH (GAPDH). The upper panel shows hybridization from one of three independent experiments. The densitometric quantification of the three experiments is summarized in the lower panel. For RS1, staining at 7.5 and 4.2 kb is summarized. Signals that differ significantly from those obtained with confluent cells grown with 5 mM D-glucose are indicated (* p < 0.01; ** p < 0.001).

In Western blot analysis, the distribution of pSGLT1 and pRS1 proteins was investigated after subcellular fractionation of LLC-PK1 cells that were grown until 2 days before or 5 days after confluence in the presence of 5 mM D-glucose (Fig. 2a). pSGLT1 was detected with the affinity-purified, subtype-specific antibody pSGLT1-ab (43) and pRS1 with the affinity-purified antibody pRS1-ab that was raised against recombinant pRS1 protein (29). In Western blots on purified brush-border membranes from pig kidney, pSGLT1-ab binds to a polypeptide band at about 75 kDa, whereas pRS1-ab detects a polypeptide band at about 100 kDa (see control in Fig. 2a). In control experiments, staining was abolished when the antibodies SGLT1-ab and pRS1-ab were pre-absorbed with the antigenic SGLT1 peptide or with purified pRS1 protein, respectively (29, 43). Whereas no immunoreactivity for SGLT1 was observed in the cytosolic or endosomal membrane fractions, SGLT1 was detected in the PME fraction (Fig. 2a, upper panel). In LLC-PK1 cells grown in 5 mM D-glucose, the concentration of SGLT1 in the PME fraction was drastically increased after confluence (Fig. 2a, upper panel). However, in the PME fraction of confluent cells grown in 25 mM D-glucose, SGLT1 protein levels were below the detection limit of our Western blot protocol (Fig. 2b). This confirms the above-described glucose-dependent down-regulation of SGLT1 and parallels the transport data.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 2.   Western blot analysis of SGLT1 and RS1 protein in subconfluent and confluent LLC-PK1 cells grown in low or high D-glucose. LLC-PK1 cells were grown in 5 or 25 mM D-glucose and harvested 2 days before or 5 days after confluence. From each preparation, a plasma membrane-enriched fraction (PME), a 200,000 × g supernatant containing cytosolic proteins (CY), and a fraction with endosomal membranes (EN) were prepared. 15 µg of protein per lane of the various fractions were subjected to SDS-polyacrylamide gel electrophoresis. The proteins were transferred to nitrocellulose membranes and immunolabeled with affinity-purified antibody against pSGLT1 or against pRS1. a shows immunoreactions with different subcellular fractions of subconfluent and confluent LLC-PK1 cells grown with 5 mM D-glucose. Porcine renal brush-border membranes served as a control. b shows immunoreactions with pSGLT1 in PME fractions that were isolated from confluent LLC-PK1 cells grown in 25 or 5 mM D-glucose. c immunoreactions with pRS1 are shown that were performed on PME fractions isolated from subconfluent and confluent LLC-PK1 cells grown in 25 or 5 mM D-glucose.

At variance with porcine renal brush-border membranes where pRS1-ab stained a single polypeptide band at 100 kDa (29), in the PME fraction of LLC-PK1 cells, polypeptide bands were detected at about 100, 60, and in some cases also at about 90 kDa (Fig. 2, a and c). In LLC-PK1 cells grown in 5 or 25 mM D-glucose, the concentration of RS1 protein in the PME fraction was much higher before than after confluence (Fig. 2a, lower panel, and c). When the cells were grown in 5 or 25 mM D-glucose, no difference in pRS1 protein was apparent before versus after confluence (Fig. 2c). The data show that pRS1 protein concentration at the plasma membrane changes dramatically and opposite to the SGLT1 protein when the cells have reached confluence. In contrast to SGLT1, the expression level of RS1 protein at the plasma membrane is not affected by the D-glucose concentration in the medium.

Overexpression of pRS1 in LLC-PK1 Cells-- To investigate whether RS1 affects the expression of SGLT1, pRS1 was overexpressed in LLC-PK1 cells. The cells were stably transfected with the pRcCMV vector containing the complete open reading frame of pRS1 downstream to the CMV promoter (cell lines S10-S13). LLC-PK1 cells stably transfected with the empty vector pRcCMV vector served as control (cell line CON3). Overexpression of pRS1 protein was verified in Western blots on homogenates of LLC-PK1 cells that were grown for 5 days after confluence in the presence of 5 mM D-glucose. The 1st lane of Fig. 3a shows a control reaction with purified brush-border membrane of porcine renal cortex. Whereas endogenous pRS1 protein was not detected in the homogenate of the control cell line (CON3 in Fig. 3a), in cell lines stably transfected with pRS1, overexpressed pRS1 was stained as a 100-kDa band (S10-S13 in Fig. 3a). The cells overexpressing RS1 exhibited a slightly higher proliferation rate as cell line CON3, reaching confluence between 6 and 7 days after seeding (Fig. 3b). After confluence, the cells overexpressing RS1 exhibited a little higher cell density than the control cells (Fig. 3b). Eleven days after seeding, total protein concentrations per cell were 0.65 ± 0.04 ng (CON3), 0.57 + 0.04 ng (S11), and 0.53 ± 0.03 ng (S12). In Fig. 3c, the activity of Na+-D-glucose co-transport was compared in cell lines overexpressing pRS1 (S10-S13), in native LLC-PK1 cells (native), and in LLC-PK1 cells that had been stably transfected with the empty vector (CON3). The cells were grown with 5 mM D-glucose and harvested 5 days after confluence, and initial uptake of 10 µM AMG was measured after 2.5 min of incubation in the presence and absence of 100 µM phlorizin. Fig. 3c shows that the phlorizin-inhibitable AMG uptake rates in cell lines S10-S13 were 5-15 times smaller than those measured in native LLC-PK1 cells and in cell line CON3. To determine whether the reduced uptake in RS1 overexpressing cells indicates a decrease of transporter affinity or maximal transport rate, the substrate dependence was measured with cell line S11. Fig. 3d shows that the maximal transport rate in cell line S11 (0.17 ± 0.01 nmol × mg-1 × min-1) was about 10 times smaller than the maximal transport rate in native LLC-PK1 cells that were grown under the same conditions (upper panel of Fig. 7, Vmax = 2.03 ± 0.05 nmol × mg-1 × min-1). The Km value for AMG uptake by cell line S11 was 0.36 ± 0.07 mM. This is half the apparent Km value of native LLC-PK1 cell lines grown and harvested under the same conditions (upper panel of Fig. 7, Km = 0.79 ± 0.04 mM). Because the plasma membrane depolarizes during Na+-D-glucose co-transport and the Km value of SGLT1 for glucose increases with decreasing membrane potential (46), the observed difference in Km may be due to the stronger depolarization in the more active native LLC-PK1 cells. The apparent Km value for AMG uptake by human SGLT1 expressed in Xenopus oocytes was increased by a similar factor when the membrane potential was decreased from -70 to -30 mV (46). To determine whether the repression of SGLT1 expression after cultivation with high D-glucose was preserved after overexpression of pRS1, cell lines S11 and S12 were grown with 5 or 25 mM D-glucose and harvested 5 days after confluence, and phlorizin-inhibitable uptake of 10 µM AMG was measured after 2.5 min of incubation. After growing S11 and S12 with 25 versus 5 mM D-glucose, AMG uptake was decreased by 55 ± 20 and 75 ± 22%, respectively (means ± S.D., n = 3, p < 0.01 for decrease of uptake). Because LLC-PK1 control cells showed about the same decrease of AMG uptake, the data suggest that the repression of AMG uptake by pRS1 and by cultivation with high D-glucose is additive.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   Characterization of LLC-PK1 cell lines that were stably transfected with pRS1. The Western blot in a shows the expression of pRS1 protein in LLC-PK1 cells stably transfected with pRS1. Homogenates from LLC-PK1 cells that were stably transfected with the pRcCMV vector containing pRS1 (lines S10-S13) are compared with a homogenate from LLC-PK1 cells stably transfected with the empty pRc/CMV vector (line CON3). 15 µg of protein were applied per lane, and the blots were developed with affinity-purified antibody against pRS1 (pRS1-ab). The reaction of pRS1-ab with porcine renal brush-border membranes (BBM) is shown as a control. b, the growth curves of the pRS1-overexpressing cell lines S11 and S12 are compared with that of the control cell line CON3. Cells were seeded at a density of 4400 cells × cm-2 and cultivated with 5 mM D-glucose in the medium. The cell density was determined from 1 to 11 days after seeding. Confluence was observed on day 6 or 7. Mean values ± S.D. from four plates are presented. c, the initial phlorizin-inhibitable uptake rates of 10 µM [14C]AMG are compared in native LLC-PK1 cells (native), in the control cell line CON3, and in four cell lines overexpressing pRS1 (S10-S13). The uptake measurements were performed with cells that were grown 5 days after confluence in the presence of 5 mM D-glucose. Phlorizin-inhibitable uptake rates ± S.D. from three culture plates are illustrated. The data are derived from three different experiments and are normalized to the uptake obtained in native LLC-PK1 cells. d, the glucose dependence of the phlorizin-inhibitable AMG uptake in the RS1-overexpressing cell line S11 is demonstrated. The Michaelis-Menten equation was fit to the data.

Next, we compared the amount of SGLT1 protein in PME fractions isolated from cell lines CON3, S11, and S12 and the amount of cellular SGLT1 mRNA in these cell lines. For these experiments, the cells were grown in 5 mM D-glucose and harvested 5 days after confluence. The Western blot in the upper panel of Fig. 4 shows that SGLT1 protein could be detected in the PME fraction of line CON3 but was not detected in the RS1-overexpressing cell lines S11 and S12. The Northern blots in the lower panel of Fig. 4 show that the decrease of SGLT1 protein in cell lines S11 and S12 mainly reflects a difference in mRNA concentrations. Compared with line CON3, the concentration of SGLT1 mRNA was dramatically decreased in cell lines S11 and S12. In contrast, the mRNA concentrations of another membrane-spanning protein (the vasopressin receptor 2, V2R) and of a cytosolic protein (glyceraldehydephosphate dehydrogenase, GAPDH) were not changed.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 4.   Decrease of SGLT1 mRNA and SGLT1 protein in LLC-PK1 cell lines that were stably transfected with pRS1. The amounts of pSGLT1 protein (upper panel) and pSGLT1 mRNA (lower panel) were compared in the control cell line CON3 and the pRS1-overexpressing cell lines S11 and S12. The cells were grown in the presence of 5 mM D-glucose and harvested 5 days after confluence. The Western blot in the upper panel was performed with plasma membrane-enriched membrane fractions (PME) that were isolated from the different cell lines. It was developed with the affinity-purified antibody against pSGLT1 (pSGLT1-ab). The Northern blots in the lower panel were hybridized with cDNA probes specific for pSGLT1, glyceraldehydephosphate dehydrogenase (GAPDH) or the vasopressin receptor type 2 (V2R).

Generation of LLC-PK1 Cell Lines Where the Expression of Endogenous pRS1 Is Reduced-- To characterize further the effect of pRS1 on the expression of SGLT1 related to confluence and extracellular D-glucose concentration, an antisense strategy was employed. We generated stably transfected LLC-PK1 cell lines that transcribe a 1.5-kb antisense pRS1-cRNA fragment that covers the ATG start codon. Most measurements were performed with cell lines containing antisense RS1 introduced with the pRc/CMV vector (cell lines AS6 and AS8). Control experiments were carried out with an LLC-PK1 cell line that was stably transfected with the empty vector (cell line CON3), with native LLC-PK1 cells, and with a LLC-PK1 cell line in which a 1.2-kb antisense construct of the porcine oxytocin receptor was stably expressed. Some experiments were also performed with an LLC-PK1 cell line where antisense RS1 was stably transfected with the pIND vector from Invitrogen (cell line AS2, see Fig. 6). In this system the transcription of RS1 can be induced by muristerone A (31). The characterization of the RS1 antisense cell lines is shown in Fig. 5. PCR and reverse transcriptase-PCR experiments showed that antisense pRS1 DNA was incorporated in the genome of the transfected LLC-PK1 cell lines (lanes d and e) and that it was transcribed into antisense RS1 RNA (lanes l and m), respectively. No reaction products were obtained with native LLC-PK1 cells (lanes c and i) or with cell line CON3 that had been stably transfected with the empty pRcCMV vector (lane k). To determine the amount of pRS1 protein associated with the plasma membrane, LLC-PK1 cells were grown in the presence of 5 mM D-glucose until 2 days before reaching confluence. Then the respective PME fractions were isolated, and pRS1 protein was analyzed by Western blots using affinity-purified pRS1-ab. In line CON3, intact pRS1 protein and additional proteolytic fragments were observed at ~60 and ~55 kDa (lane o). In contrast, the antisense RS1 cell lines AS6 and AS8 contained no intact pRS1 protein and largely reduced amounts of the proteolytic fragments (lanes p and q).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 5.   Expression of pRS1 in LLC-PK1 cell lines that were stably transfected with antisense pRS1. LLC-PK1 cell lines were stably transfected with the pRcCMV vector containing antisense pRS1 (AS6 and AS8) or with the empty vector (CON3). Five days after confluence, genomic DNA (upper panel), mRNA (middle panel), or the plasma membrane enriched fraction PME (lower panel) were isolated. In polymerase chain reaction analysis, fragments of RS1 were amplified directly (upper panel) or after reverse transcription (middle panel). No specific amplification was obtained with water (lanes b and h), with DNA or RNA from native LLC-PK1 cells (lanes c and i), or with RNA from the control cell line CON3 (lane k). The upper panel shows the genomic integration of antisense pRS1 in lines AS6 and AS8. The transcription of the RS1 antisense fragment is demonstrated in the middle panel. The lower panel shows a Western blot of plasma membranes that were isolated from porcine renal brush-border membranes (lanes n and r), the control LLC-PK1 cell line CON3 (lane o), or from the pRS1 antisense cell lines AS6 and AS8 (lanes p and q). The antibody staining of pRS1 was performed with the affinity purified antibody pRS1-ab that identifies intact pRS1 as a 100-kDa polypeptide band.

To test whether proliferation and/or cell size was altered in the antisense pRS1 cell lines, we determined the cell density and protein content 5 days after confluence. The antisense pRS1 cell lines, native LLC-PK1 cells, and the control cell line CON3 all reached confluence between 6 and 8 days after seeding. The cell densities determined 5 days after reaching confluence were not significantly different: native LLC-PK1 cells 1.3 ± 0.2, CON3 1.3 ± 0.2, AS6 0.9 ± 0.1, and AS8 1.0 ± 0.1 (× 105 cells/cm2, means ± S.D. from three independent experiments). Similarly, the protein contents per cell were not significantly different between cell lines: native LLC-PK1 cells 0.71 ± 0.15, CON3 0.70 ± 0.15, AS6 0.64 ± 0.03, and AS8 0.84 ±+ 0.03 (ng/cell, means ± S.D., n = 3).

Na+-D-Glucose Co-transport Activity in RS1 Antisense Cell Lines-- First, we examined the initial rates of phlorizin-inhibitable uptake of AMG in the pRS1 antisense cell lines as compared with various control cell lines. As the expression of SGLT1 in LLC-PK1 cells is lower when the cells are grown in 25 mM D-glucose as compared with 5 mM D-glucose (17, 18), both conditions were tested. The initial uptake rates of 40 µM [14C]AMG were measured with suspended cells that had been grown until 5 days after confluence. Fig. 6 (upper panel) shows similar initial phlorizin-inhibitable glucose uptake rates in three different control cell lines, i.e. in native LLC-PK1 cells, in cell line CON3, which was stably transfected with the empty pRcCMV vector, and in the uninduced pRS1 antisense cell line AS2. Five to ten times higher initial uptake rates were observed in all three cell lines when cells were grown in the presence of 5 mM D-glucose instead of 25 mM D-glucose. With an LLC-PK1 cell line stably transfected with a 1.2-kb antisense construct of the porcine oxytocin receptor, AMG uptake rates were obtained that were in the range of the other control cell lines (data not shown). In the pRS1 antisense cell lines up-regulation of Na+-D-glucose co-transport as compared with controls was observed (lower panel). This effect was dramatic in cells that were grown with 25 mM D-glucose in the medium. It was smaller when the basal Na+-D-glucose co-transport activity was increased during cultivation with 5 mM D-glucose. Under this condition the up-regulation in cell line AS6 was not statistically significant (Fig. 6). The smaller up-regulation in the RS1 antisense cell lines after cultivation with 5 mM D-glucose compared with 25 mM D-glucose may be due to a limited capacity of LLC-PK1 cells to express Na+-D-glucose co-transport activity.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of RS1 on the expression of Na+-D-glucose co-transport in LLC-PK1 cells grown in high or low glucose. Control LLC-PK1 cells (upper panel) and pRS1 antisense LLC-PK1 cells (lower panel) were grown with 25 mM D-glucose (shaded bars) or 5 mM D-glucose in the medium (open bars). Five days after confluence, the cells were harvested and washed in transport medium, and the initial uptake rates of 40 µM [14C]AMG were determined after 2.5 min of incubation in the absence and presence of 100 µM phlorizin. Phlorizin-inhibitable uptake rates are presented as mean values ± S.E. of triplicate experiments. Native LLC-PK1 cells (native), control cell line CON3, non-induced cell line AS2 (AS2 uninduced), pRS1 antisense cell lines AS6 and AS8, and the muristerone-induced RS1 antisense cell line AS2 (AS2 induced) were compared.

To distinguish whether the increase of AMG uptake in the pRS1 antisense cell lines reflects an increase in Vmax or a decrease of Km, the concentration dependence of AMG uptake was compared in the antisense pRS1 cell line AS8 and native LLC-PK1 cells. Fig. 7 shows the concentration dependence of phlorizin-inhibitable [14C]AMG uptake in native LLC-PK1 cells and line AS8 which were grown 5 days after reaching confluence with 5 or 25 mM D-glucose in the medium. The Michaelis-Menten equation was fit to the data. The following Vmax values (nmol × mg-1 × min-1) and apparent Km values (mM) were calculated as follows: native cells in 25 mM D-glucose, Vmax = 0.30 ± 0.02, Km = 0.42 ± 0.07; native cells in 5 mM D-glucose, Vmax = 2.03 ± 0.05, Km = 0.79 ± 0.04; AS8 in 25 mM D-glucose, Vmax = 5.61 ± 0.22, Km = 0.84 ± 0.07; AS8 in 5 mM D-glucose, Vmax = 9.62 ± 0.73, Km = 1.01 ± 0.16. The 2-fold higher Km value in native cells grown in 5 mM D-glucose as compared with cells grown in 25 mM D-glucose is probably due to a more pronounced membrane depolarization at higher uptake rates of this electrogenic transporter as discussed above. Thus, probably only the Vmax of AMG uptake is decreased when native cells are grown with 25 instead of 5 mM D-glucose. Analogously, the data are compatible with the notion that depletion of pRS1 entails an increase in Vmax without changing the Km value of AMG transport as shown by line AS8. Comparing the Vmax values of AS8 cells grown in the presence of 5 or 25 mM D-glucose in four independent experiments revealed no significant difference (9.6 ± 0.8 versus 9.5 ±+ 3.0 pmol × mg-1 × min-1).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of RS1 on the substrate dependence of Na+-D-glucose co-transport in LLC-PK1 cells. Native LLC-PK1 cells (upper panel) and cells of the pRS1 antisense cell line AS8 (lower panel) were grown in 25 mM D-glucose (closed symbols) or with 5 mM D-glucose (open symbols). Five days after confluence, the cells were harvested and analyzed for initial rates of [14C]AMG uptake at different AMG concentrations in the absence or presence of 100 µM phlorizin as in Fig. 6. Mean values ± S.D. (n = 3) of phlorizin-inhibitable uptake rates are plotted versus the AMG concentrations. The Michaelis-Menten equation was fit to the data.

SGLT1 Protein in the Plasma Membrane of pRS1 Antisense Cell Lines-- To determine whether the Vmax increase of Na+-D-glucose co-transport in RS1 antisense cells is due to an increased number of SGLT1 transporters in the plasma membrane, we assessed the amount of SGLT1 protein in the PME fraction of LLC-PK1 cells by Western blotting using affinity-purified pSGLT1-ab. In native LLC-PK1 cells (upper lane of Fig. 2) and in the control line CON3 (data not shown), SGLT1 protein was only detectable in confluent cells. Five days after reaching confluence of native cells or line CON3, the amount of SGLT1 protein was significantly higher in cells grown in 5 mM D-glucose as compared with 25 mM D-glucose (Figs. 2 and 8). In confluent pRS1 antisense cells, the amount of SGLT1 protein in the PME fraction was drastically increased under both conditions (Fig. 8, upper panel). In the bottom panel of Fig. 8, the staining of SGLT1 is shown for cell lines CON3 and AS8 that were grown for 5 days after reaching confluence in 25 mM D-glucose. In line AS8, the amount of SGLT1 protein was more than 20 times larger than in line CON3. The observation that the increase of SGLT1 protein in RS1 antisense cell line AS8 was more pronounced than the increase in Vmax of Na+-D-glucose co-transport may be explained by the presence of subapical membrane vesicles containing SGLT1 in the PME fraction.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 8.   Effects of RS1 on the amount of SGLT1 protein in the PME fraction of LLC-PK1 cells grown in high or low glucose medium. Control LLC-PK1 cells (CON3) and RS1 antisense cells (AS6 and AS8) were grown in the presence of 5 mM D-glucose (5G) or 25 mM D-glucose (25G) and harvested 5 days after reaching confluence. PME fractions were isolated and separated by SDS-polyacrylamide gel electrophoresis, and SGLT1 protein was analyzed in Western blots as in Fig. 2. In the upper panel, each lane was loaded with 10 µg of protein. In the lower panel, the indicated amounts of plasma membrane protein were loaded.

Effect of RS1 on SGLT1 mRNA-- mRNA was isolated from different LLC-PK1 cell lines grown in 25 and 5 mM D-glucose and hybridized with cDNA probes specific for pSGLT1, GAPDH, or the vasopressin receptor V2R (Fig. 9). Similar to native LLC-PK1 cells (see Fig. 1), the 3.9- and the 2.2-kb transcripts of SGLT1 were decreased 3-fold in control cells CON3 (p < 0.001) when the cells were grown in 25 mM D-glucose as compared with 5 mM D-glucose. This glucose-dependent decrease of SGLT1 message was not observed for GAPDH and for the vasopressin receptor V2R. In the RS1 antisense cell lines AS6 and AS8, the staining of both SGLT1 transcripts was increased in contrast to GAPDH and V2R. The increase of SGLT1 mRNA was between 4- and 11-fold after culture in 5 mM D-glucose (p < 0.05 for AS6 and p < 0.001 for AS8) and between 4- and 9-fold after culture in 25 mM D-glucose (p < 0.05 for AS6 and p < 0.001 for AS8). In the antisense cell lines AS6 and AS8, the decrease in SGLT1 mRNA in 25 mM D-glucose as compared with 5 mM D-glucose was between 2- and 5-fold. Statistical significance of the glucose-dependent decrease of SGLT1 mRNA in AS6 and AS8 was only obtained when the staining of both SGLT1 transcripts was summed up (p < 0.01 for AS6, p < 0.05 for AS8).


View larger version (73K):
[in this window]
[in a new window]
 
Fig. 9.   Northern blot analysis of SGLT1, GAPDH, and V2R in confluent RS1 antisense cell lines grown in low and high glucose medium. Control LLC-PK1 cells (CON3) and RS1 antisense cells (AS6 and AS8) were cultivated in the presence of 5 or 25 mM D-glucose and harvested 5 days after reaching confluence, and mRNAs were prepared. 5 µg of mRNA per lane were separated on agarose gels in the presence of glyoxal, blotted to nylon membranes, and hybridized with radiolabeled cDNAs of pSGLT1 (SGLT1), human glyceraldehydephosphate dehydrogenase (GAPDH), or the porcine vasopressin receptor (V2R). For each gene four hybridizations were performed employing separate agarose gels of two independent cultivations. Typical autoradiographs are shown in which the films were exposed for 8 h. The densitometric quantification of the four hybridizations is summarized in the lower panel. Hybridization signals are indicated that differ significantly from the hybridization obtained with line CON3 grown with the respective glucose concentration (black-square, p < 0.01; black-triangle, p < 0.05). Comparing the cultivation with 5 and 25 mM D-glucose, the staining differences in each of the two SGLT1 transcripts in cell line CON3 were significantly different (* p < 0.001). In cell lines AS6 and AS8, the staining differences after cultivation in 5 and 25 mM D-glucose were significantly different when the stainings of both SGLT1 transcripts were summarized (p < 0.05).

To determine whether the effect of RS1 on SGLT1 expression is related to confluence of the cells, we next investigated whether in the RS1 antisense cell lines SGLT1 mRNA was already increased before confluence. In four independent experiments, cell lines CON3, AS6, and AS8 were grown to about 60% confluence in the presence of 5 mM D-glucose. The mRNAs were isolated, separated on agarose gels, and hybridized with cDNA probes specific for pSGLT1 and GAPDH. Fig. 10 shows that before confluence SGLT1 mRNA was not significantly increased in the RS1 antisense cell lines. We also compared the phlorizin-inhibitable uptake rates of 40 µM AMG in cell lines CON3, AS6, and AS8 that were grown to 60% confluence in the presence of 5 mM D-glucose or 25 mM D-glucose. From three independent experiments the following uptake rates (in pmol × mg protein-1 × min-1) were obtained: 5 mM D-glucose 0.44 ± 0.08 (CON3), 0.48 ± 0.04 (AS6), 0.40 ± 0.09 (AS8); 25 mM D-glucose 0.36 ± 0.04 (CON3), 0.32 ± 0.04 (AS6), 0.32 ± 0.04 (AS8). The data show that the expression of SGLT1 is not significantly different in subconfluent RS1 antisense and control LLC-PK1 cells irrespective as to whether they have been grown with 5 or 25 mM D-glucose. This indicates that the effect of pRS1 only applies after polarization of LLC-PK1 cells.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 10.   Northern blot analysis of SGLT1 and GAPDH in subconfluent RS1 antisense cell lines grown in low glucose. Control cell line CON3 and the RS1 antisense LLC-PK1 cell lines AS6 and AS8 were grown in 5 mM D-glucose and harvested at about 60% confluence. Northern blots were performed with radiolabeled cDNAs of pSGLT1 and hGAPDH as in Fig. 9. The hybridizations were performed on four mRNA preparations from independent experiments. In the upper panel a typical autoradiograph is shown in which the film was exposed for 3 days. In the lower panel the quantification of the experiments is presented. No significant differences in hybridization between line CON3 and lines AS6 or AS8 were detected.

A preliminary set of experiments was performed to evaluate whether the RS1-dependent regulation of SGLT1 observed in confluent LLC-PK1 cells is specific for this plasma membrane transporter. In Northern blots, the cDNA probes of two other plasma membrane transporters, the Na+-independent glucose transporter GLUT1 (35) and the polyspecific organic cation transporter OCT2 (36), and a cDNA probe of the cytosolic protein ubiquitin were hybridized to mRNAs isolated from cell lines CON3, AS6, and AS8. The cell lines were grown 5 days after reaching confluence in the presence of 5 mM D-glucose. The hybridization signal of the Northern blots was quantified and normalized to the signal of cell line CON3. From two independent experiments, the data obtained with both RS1 antisense cell lines (AS6 and AS8) were combined. The relative signal intensities of RS1 antisense cell lines were 1.80 ± 0.17 for GLUT1, 1.19 ± 0.54 for OCT2 and 1.18 ± 0.22 for ubiquitin. The increase of GLUT1 mRNA in the RS1 antisense cell lines was statistically significant (p < 0.01); however, it was much less pronounced than the mRNA increase of SGLT1.

To investigate whether the effects of RS1 on SGLT1 mRNA concentration represent changes in the rate of transcription or in message stability, we compared the degradation of the two SGLT1 mRNA transcripts in native LLC-PK1 cells and in RS1 antisense cell lines AS6 or AS8. The cells were grown with 5 mM D-glucose for 5 days after confluence. Then 25 µg/ml of the RNA polymerase II inhibitor DRB was added to the medium, and the cells were harvested at time intervals between 1 and 20 h. Northern blots were performed and hybridized with SGLT1 cDNA. The two mRNA transcripts were quantified by densitometry. Two independent experiments revealed that the message stability of the SGLT1 transcripts in the RS1 antisense cell line was not changed significantly (data not shown). These data suggest that the transcription of SGLT1 is inhibited by RS1. To validate this interpretation and to determine whether RS1 influences the transcription of GLUT1 and OCT2, we performed nuclear run-on assays with the control cell line CON3 and cell lines AS6 and AS8. For these experiments, the cells were grown with 5 mM D-glucose and harvested 5 days after confluence, and the nuclei were isolated and washed. After 30 min of incubation of the nuclei with radioactively labeled uridine triphosphate, the newly synthesized mRNA was isolated and hybridized to membrane-bound cDNAs of hGLUT1, hOCT2, pSGLT1, and of a fragment of the lacI gene which served as a control for nonspecific binding. Identical results were obtained from two independent experiments showing that the synthesis of SGLT1 mRNA in the RS1 antisense cell lines AS6 and AS8 was significantly (p < 0.01) increased by a factor of about 10 (Fig. 11). The synthesis of GLUT1 mRNA was not changed significantly, whereas the synthesis of hOCT2 mRNA was increased by a factor of 2 (p < 0.05).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 11.   Nuclear run-on assay in RS1 antisense LLC-PK1 cells. LLC-PK1 cells stably transfected with pRcCMV vector (CON3) or pRcCMV vector containing antisense RS1 (AS6 and AS8) were grown in the presence of 5 mM D-glucose and harvested 5 days after confluence. The nuclei were isolated and incubated with ATP, GTP, CTP, and [alpha -32P]UTP for 30 min. The mRNAs were isolated, and equal amounts of radioactive mRNAs were used to hybridize purified cDNA fragments of hGAPDH, hGLUT1, hOCT2, LacI, and pSGLT1 that were immobilized on nylon filters. The upper panel shows an autoradiograph of one experiment. The staining of this and a second independent experiment (four dots for each gene and cell line) was quantified densitometrically. In the lower panel the mean values ± S.D. of the signal intensities are presented. Significant differences between line CON3 and lines AS6 or AS8 are indicated (* p < 0.05, **p < 0.01).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The amount of the Na+-D-glucose co-transporter molecules in the plasma membrane may be changed within minutes via endo- and exocytosis (14). In contrast, the transcriptional regulation of SGLT1 is known to occur more slowly. The expression of SGLT1 is altered via changes of intracellular mRNA concentrations that were reported to be mediated by factors either directly affecting the transcription (11) or the stability of the mRNA (21, 25). When LLC-PK1 cells grown in 5 mM D-glucose differentiate during confluence, the cytosolic concentration of SGLT1 mRNA increases. In contrast, SGLT1 mRNA decreases when the cells de-differentiate after being detached mechanically or by trypsin treatment (19, 22). In confluent LLC-PK1 cells, the concentration of cytosolic SGLT1 mRNA is also dependent on the concentration of D-glucose in the incubation medium (17). In the past, many studies have been performed in LLC-PK1 cells to resolve the mechanisms that underlie these mRNA changes. They identified a correlation between the increase of SGLT1 mRNA during confluence with an increase of the intracellular cAMP and showed that SGLT1 mRNA was increased by cAMP-elevating agents (22). Furthermore, it was revealed that the cAMP-dependent increase of SGLT1 mRNA relied on a decelerated message degradation that was mediated by binding of a cytosolic protein to a defined 3' region of mRNA (21, 25). In addition, it was found that the decrease of SGLT1 mRNA during de-differentiation can be blocked or accelerated by inhibition or stimulation of protein kinase C, respectively (19). Concerning the regulation of SGLT1 in LLC-PK1 cells, many questions have remained unsolved. For example, it is not known which signaling mechanisms underlie the up-regulation of SGLT1 when LLC-PK1 cells are gaining confluence, which cellular events induce the decrease of SGLT1 message during de-differentiation of the LLC-PK1 cells, and how protein kinase C affects the concentration of SGLT1 mRNA.

In this paper, we present data that show that the previously cloned 67-kDa polypeptide RS1 (26) is involved in transcriptional regulation of the Na+-D-glucose co-transporter SGLT1 in LLC-PK1 cells. We generated stably transfected LLC-PK1 cell lines that either overexpress RS1 or transcribe antisense mRNA of RS1 and thereby suppress the translation of endogenous RS1. Opposite effects were obtained by both maneuvers. In the cell lines overexpressing RS1, SGLT1 mRNA, SGLT1 protein, and the Na+-D-glucose co-transport activities were decreased, whereas in RS1 antisense cell lines message, protein, and Na+-D-glucose transport activities were dramatically increased. Because the stability of SGLT1 mRNA was not significantly changed in RS1 antisense cells and the transcription of SGLT1 was largely increased in a nuclear run-on assay, our data suggest that RS1 is involved in the repression of SGLT1 transcription. Some selectivity for SGLT1 of this RS1 effect is proposed because the transcription of GAPDH and GLUT1 was not changed in the RS1 antisense cell lines, and the observed increase in transcription of the organic cation transporter OCT2 was much smaller than that of SGLT1. Interestingly, in the RS1 antisense cell lines, the message of SGLT1 was only increased when the cells were grown until after confluence. This indicates that RS1-mediated effects upon SGLT1 expression only apply in polarized cells forming a closed monolayer. Depletion of RS1 in subconfluent cells is not sufficient to initiate the up-regulation of SGLT1 but RS1 may act in concert with other factors that are involved in the confluence-dependent up-regulation of SGLT1. Because the concentration of RS1 at the plasma membrane was drastically reduced after confluence, RS1 may play an important role during this regulation.

Our data suggest that RS1 does not participate in the glucose-dependent down-regulation of SGLT1 in LLC-PK1 cells. After cultivation of LLC-PK1 cells with 25 mM D-glucose versus 5 mM D-glucose, glucose transport by SGLT1 was reduced to a similar extent in controls and pRS1-overexpressing cells. Also, after cultivation with 25 mM D-glucose versus 5 mM D-glucose, SGLT1 mRNA was reduced to a similar extent in controls and RS1 antisense LLC-PK1 cells. In controls and RS1 antisense cells, the decrease of SGLT1 mRNA was correlated with a decrease of SGLT1 protein in a plasma membrane-enriched membrane fraction. The finding that the glucose-induced decrease of SGLT1 protein in the RS1 antisense cells was not combined with a significant decrease of the maximal D-glucose transport rate, as observed in control cells, is probably due to a limited capacity of the plasma membrane for functional active transporter molecules.

To avoid over-interpretation of the data, it must be kept in mind that stable overexpression or reduction of RS1 by antisense strategies may lead to complex changes in the cells. For example, concentration and activity of intracellular regulatory proteins and second messengers may change. Even the increase in the transcription of SGLT1 in isolated nuclei can rather be an effect that is mediated by the up-regulation or activation of cytosolic proteins that are translocated into the nucleus and activate transcription. However, since opposite effects were obtained after overexpressing RS1 and reducing endogenous RS1 in our stably transfected cell lines, and since we have recently been able to demonstrate that RS1 actually migrates into the nucleus,2 we hypothesize that RS1 is a plasma membrane-associated protein that migrates into the nucleus to act as an inhibitory transcription factor for SGLT1.

To discuss further the function of RS1, previous data must be recalled and re-evaluated. We identified porcine RS1 (pRS1) after screening an expression library with a monoclonal antibody raised against renal brush-border membrane proteins (26), and we cloned proteins with amino acid identities of 74 and 65% from human (hRS1) and rabbit (rbRS1), respectively (28, 45). RS1 is a rather hydrophilic protein with two conserved consensus sequences for protein kinase C, three conserved consensus sequences for casein kinase II, and a conserved C terminus of 42 amino acids that contains a consensus sequence for a ubiquitin-associated domain (47, 48) and a short hydrophobic alpha -helix at the C-terminal end (26). We showed that hRS1 is an intronless single copy gene that localizes to chromosome 1.p36.1 (45). Performing labeling experiments with membrane-impermeant reagents on oocytes of Xenopus laevis expressing RS1, we recently localized RS1 to the intracellular side of the plasma membrane (29). Functional activity of RS1 was originally concluded from effects that were observed when RS1 was expressed after cRNA injection into Xenopus oocytes (26, 28, 45). When RS1 was expressed alone, the membrane surface area was reduced (29), and after co-expression of hRS1 with human SGLT1, the Vmax of expressed glucose co-transport and the amount of expressed SGLT1 protein in the plasma membrane were decreased (28, 45). The effect of RS1 on the expression of SGLT1 in X. oocytes is not specific for this plasma membrane transporter as originally assumed (26) because the transport activity expressed by the human cation transporter OCT2 was also reduced upon co-expression with RS1 (28). However, it apparently does not concern all plasma membrane proteins because the expression of some other plasma membrane transporters was not changed (26). The effects of RS1 observed in Xenopus oocytes probably represent functional activity of RS1 protein at the plasma membrane that is independent of transcription. First, in the employed oocyte expression system, RS1 and SGLT1 were expressed by the injection of their cRNAs. Second, identical results were obtained when the experiments were performed in the absence or presence of the transcription blocker actinomycin D.3 Possible functions of RS1 at the plasma membrane are an involvement in endo- or exocytosis or an involvement in the degradation of a subset of plasma membrane transporters.

Further experiments are required to determine how RS1 is activated at the plasma membrane and by what mechanism RS1 exhibits the described effects on the transcription of SGLT1. The disappearance of RS1 during confluence of LLC-PK1 cells suggests an activation of RS1 that may occur at the plasma membrane. A similar type of dual function has been reported for beta -catenin. On the one hand, beta -catenin links cadherin in adhesion receptors to the actin cytoskeleton, and on the other hand it stimulates gene expression by binding to transcription factors (49). The proposed function of RS1 has also similarities to the sterol regulatory element-binding protein pathway where the metabolism of cholesterol is regulated by a sterol-dependent release of transcription factors called sterol regulatory element-binding proteins from the endoplasmic reticulum (50). It will be a challenge to characterize further the regulatory pathway of RS1 and to identify physiological regulations that involve RS1.

    ACKNOWLEDGEMENT

We thank Michael Christof for preparing the figures.

    FOOTNOTES

* This work was supported by the Deutsche Forschungsgemeinschaft Grant SFB 487/C1.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Both authors contributed equally to this work.

§ To whom correspondence should be addressed: Anatomisches Institut, Koellikerstr. 6, 97070 Würzburg, Germany. Fax: 0931 312087; E-mail: Hermann@Koepsell.de.

Published, JBC Papers in Press, September 18, 2001, DOI 10.1074/jbc.M105975200

2 T. Kühlkamp, K. Baumgarten, M. Akimjanova, V. Gorboulev, and H. Koepsell, manuscript in preparation.

3 M. Veyhl and H. Koepsell, unpublished data.

    ABBREVIATIONS

The abbreviations used are: DMEM, Dulbecco's modified Eagle's medium; DPBS, Dulbecco's phosphate-buffered saline; PCR, polymerase chain reaction; nt, nucleotides; DRB, 5,6-dichloro-1-beta -D-ribofuranosylbenzimidazole; PMSF, phenylmethylsulfonyl fluoride; AMG, methyl-alpha -D-glucopyranoside; kb, kilobase pair; bp, base pair; GAPDH, glyceraldehydphosphate dehydrogenase; hGAPDH, human GAPDH; PME, plasma membrane-enriched; V2R, vasopressin receptor 2; CMV, cytomegalovirus.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Hediger, M. A., and Rhoads, D. B. (1994) Physiol. Rev. 74, 993-1026
2. Bell, G. I., Burant, C. F., Takeda, J., and Gould, G. W. (1993) J. Biol. Chem. 268, 19161-19164
3. Klip, A., Tsakiridis, T., Marette, A., and Ortiz, P. A. (1994) FASEB 8, 43-53
4. Pessin, J. E., and Bell, G. I. (1992) Annu. Rev. Physiol. 54, 911-930
5. James, D. E., Piper, R. C., and Slot, J. W. (1994) Trends Cell Biol. 4, 120-126
6. Ferraris, R. P., and Diamond, J. (1992) Am. J. Physiol. 262, G1069-G1073
7. Shirazi-Beechey, S. P., Hirayama, B. A., Wang, Y., Scott, D., Smith, M. W., and Wright, E. M. (1991) J. Physiol. (Lond.) 437, 699-708
8. Oku, A., Ueta, K., Arakawa, K., Ishihara, T., Nawano, M., Kuronuma, Y., Matsumoto, M., Saito, A., Tsujihara, K., Anai, M., Asano, T., Kanai, Y., and Endou, H. (1999) Diabetes 48, 1794-1800
9. Ayo, S. H., Radnik, R., Garoni, J. A., Troyer, D. A., and Kreisberg, J. I. (1991) Am. J. Physiol. 261, F571-F577
10. Heilig, C. W., Concepcion, L. A., Riser, B. L., Freytag, S. O., Zhu, M., and Cortes, P. (1995) J. Clin. Invest. 96, 1802-1814
11. Rhoads, D. B., Rosenbaum, D. H., Unsal, H., Isselbacher, K. J., and Levitsky, L. L. (1998) J. Biol. Chem. 273, 9510-9516
12. Ishikawa, Y., Eguchi, T., and Ishida, H. (1997) Biochim. Biophys. Acta 1357, 306-318
13. Cheeseman, C. I. (1997) Am. J. Physiol. 273, R1965-R1971
14. Hirsch, J. R., Loo, D. D. F., and Wright, E. M. (1996) J. Biol. Chem. 271, 14740-14746
15. Hull, R. N., Cherry, W. R., and Weaver, G. W. (1976) In Vitro 12, 670-677
16. Amsler, K., and Cook, J. S. (1982) Am. J. Physiol. 242, C94-C101
17. Ohta, T., Isselbacher, K. J., and Rhoads, D. B. (1990) Mol. Cell. Biol. 10, 6491-6499
18. Moran, A., Turner, R. J., and Handler, J. S. (1983) J. Biol. Chem. 258, 15087-15090
19. Shioda, T., Ohta, T., Isselbacher, K. J., and Rhoads, D. B. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11919-11923
20. Peng, H., and Lever, J. E. (1995) J. Biol. Chem. 270, 23996-24003
21. Peng, H., and Lever, J. E. (1995) J. Biol. Chem. 270, 20536-20542
22. Yet, S. F., Kong, C. T., Peng, H., and Lever, J. E. (1994) J. Cell. Physiol. 158, 506-512
23. Lasheras, C., Scott, J. A., and Rabito, C. A. (1988) Am. J. Physiol. 255, C745-C753
24. Amsler, K., Ghatani, S., and Hemmings, B. A. (1991) Am. J. Physiol. 260, C1290-C1299
25. Lee, W. Y., Loflin, P., Clancey, C. J., Peng, H., and Lever, J. E. (2000) J. Biol. Chem. 275, 33998-34008
26. Veyhl, M., Spangenberg, J., Püschel, B., Poppe, R., Dekel, C., Fritzsch, G., Haase, W., and Koepsell, H. (1993) J. Biol. Chem. 268, 25041-25053
27. Haase, W., Heitmann, K., Friese, W., Ollig, D., and Koepsell, H. (1990) Eur. J. Cell Biol. 52, 297-309
28. Reinhardt, J., Veyhl, M., Wagner, K., Gambaryan, S., Dekel, C., Akhoundova, A., Korn, T., and Koepsell, H. (1999) Biochim. Biophys. Acta 1417, 131-143
29. Valentin, M., Kühlkamp, T., Wagner, K., Krohne, G., Arndt, P., Baumgarten, K., Weber, W.-M., Segal, A., Veyhl, M., and Koepsell, H. (2000) Biochim. Biophys. Acta 1468, 367-380
30. Kimmich, G. A., Randles, J., and Wilson, J. (1994) Am. J. Physiol. 267, C1119-C1129
31. No, D., Yao, T.-P., and Evans, R. M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 3346-3351
32. Cress, W. D., and Triezenberg, S. J. (1991) Science 251, 87-90
33. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159
34. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
35. Mueckler, M., and Lodish, H. F. (1986) Cell 44, 629-637
36. Gorboulev, V., Ulzheimer, J. C., Akhoundova, A., Ulzheimer-Teuber, I., Karbach, U., Quester, S., Baumann, C., Lang, F., Busch, A. E., and Koepsell, H. (1997) DNA Cell Biol. 16, 871-881
37. Gorbulev, V., Büchner, H., Akhundova, A., and Fahrenholz, F. (1993) Eur. J. Biochem. 215, 1-7
38. Farrell, C. R., Boado, R. J., and Pardridge, W. M. (1992) Mol. Brain Res. 15, 221-226
39. Tanaka, T., Kishi, K., Igawa, M., Takase, S., and Goda, T. (1998) Biochem. J. 331, 225-230
40. Moran, A., Handler, J. S., and Turner, R. J. (1982) Am. J. Physiol. 243, C293-C298
41. Laemmli, U. K. (1970) Nature 227, 680-685
42. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354
43. Poppe, R., Karbach, U., Gambaryan, S., Wiesinger, H., Lutzenburg, M., Kraemer, M., Witte, O. W., and Koepsell, H. (1997) J. Neurochem. 69, 84-94
44. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254
45. Lambotte, S., Veyhl, M., Köhler, M., Morrison-Shetlar, A. I., Kinne, R. K. H., Schmid, M., and Koepsell, H. (1996) DNA Cell Biol. 15, 769-777
46. Hirayama, B. A., Lostao, M. P., Panayotova-Heiermann, M., Loo, D. D. F., Turk, E., and Wright, E. M. (1996) Am. J. Physiol. 270, G919-G926
47. Dieckmann, T., Withers-Ward, E. S., Jarosinski, M. A., Liu, C. F., Chen, I. S., and Feigon, J. (1998) Nat. Struct. Biol. 5, 1042-1047
48. Schultz, J., Milpetz, F., Bork, P., and Ponting, C. P. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 5857-5864
49. Ben-Ze'ev, A., and Geiger, B. (1998) Curr. Opin. Cell. Biol. 10, 629-639
50. Brown, M. S., and Goldstein, J. L. (1997) Cell 89, 331-340


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. J. Lee, J. S. Heo, H. N. Suh, M. Y. Lee, and H. J. Han
Interleukin-6 stimulates {alpha}-MG uptake in renal proximal tubule cells: involvement of STAT3, PI3K/Akt, MAPKs, and NF-{kappa}B
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1036 - F1046.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Vernaleken, M. Veyhl, V. Gorboulev, G. Kottra, D. Palm, B.-C. Burckhardt, G. Burckhardt, R. Pipkorn, N. Beier, C. van Amsterdam, et al.
Tripeptides of RS1 (RSC1A1) Inhibit a Monosaccharide-dependent Exocytotic Pathway of Na+-D-Glucose Cotransporter SGLT1 with High Affinity
J. Biol. Chem., September 28, 2007; 282(39): 28501 - 28513.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Kroiss, M. Leyerer, V. Gorboulev, T. Kuhlkamp, H. Kipp, and H. Koepsell
Transporter regulator RS1 (RSC1A1) coats the trans-Golgi network and migrates into the nucleus
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1201 - F1212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Veyhl, T. Keller, V. Gorboulev, A. Vernaleken, and H. Koepsell
RS1 (RSC1A1) regulates the exocytotic pathway of Na+-D-glucose cotransporter SGLT1
Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1213 - F1223.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. Jiang, O. Prokopenko, L. Wong, M. Inouye, and O. Mirochnitchenko
IRIP, a New Ischemia/Reperfusion-Inducible Protein That Participates in the Regulation of Transporter Activity
Mol. Cell. Biol., August 1, 2005; 25(15): 6496 - 6508.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Osswald, K. Baumgarten, F. Stumpel, V. Gorboulev, M. Akimjanova, K.-P. Knobeloch, I. Horak, R. Kluge, H.-G. Joost, and H. Koepsell
Mice without the Regulator Gene Rsc1A1 Exhibit Increased Na+-D-Glucose Cotransport in Small Intestine and Develop Obesity
Mol. Cell. Biol., January 1, 2005; 25(1): 78 - 87.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. M. Bormans, G. Van Oosterwyck, T. J. de Groot, M. Veyhl, L. Mortelmans, A. M. Verbruggen, and H. Koepsell
Synthesis and Biologic Evaluation of 11C-Methyl-D-Glucoside, a Tracer of the Sodium-Dependent Glucose Transporters
J. Nucl. Med., July 1, 2003; 44(7): 1075 - 1081.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/48/45330    most recent
M105975200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korn, T.
Right arrow Articles by Koepsell, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korn, T.
Right arrow Articles by Koepsell, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement